WA-KYMETA/LEPTON
18.8.2020 15:02:14 CEST | Business Wire | Press release
Kymeta Corporation (www.kymetacorp.com ), the communications company making mobile global—is excited to announce the successful acquisition of Lepton Global Solutions LLC (www.leptonglobal.com ), which will become a wholly owned direct subsidiary of Kymeta Corporation. Established in 2013, Lepton Global Solutions is a leading provider of satellite-based customized turnkey communications solutions and services with expertise in the Intelligence Community (IC), Special Operations Command (SOC) and other government sectors.
Acquiring Lepton combines critical capabilities and strengthens Kymeta’s ability to pursue key opportunities with U.S. defense and government customers in locations around the world. As a rapidly growing satellite communication services provider with a global and scalable network infrastructure, the company provides customized end-to-end connectivity solutions that can be deployed quickly and efficiently to meet the needs of customers wherever they are located.
Lepton currently hosts Kymeta’s satellite connectivity solutions. As a combined entity, the new offerings and capabilities bring unique, complete, bundled solutions to the market based on best-in-class technologies and tailored customer-centric services that meet and exceed customer mission requirements.
“Having a turnkey satellite service provider like Lepton accelerates Kymeta’s ability to successfully penetrate U.S. Military and Government customers in partnership with a well-established brand, deep channel experience, and network support for those verticals. The combination of Kymeta’s revolutionary hardware, together with Lepton’s service offerings, will be a winning combination that will be hard to beat. We are excited to bring Rob Weitendorf, Isabel LeBoutillier, and their team into the Kymeta family and thus expand and accelerate our ability to go to market,” said Walter Berger, President and COO of Kymeta.
“Government and commercial sectors need the most reliable and seamless connectivity to successfully fulfill their daily missions,” said Rob Weitendorf, Managing Partner at Lepton. “This new venture will enable our customers to leverage the expertise of Lepton and Kymeta to receive more customized services and solutions, while maintaining Lepton’s legacy of providing the best-of-breed solutions always with a focus on the customer’s mission.” Mr. Weitendorf goes on to say, “I can’t think of a better partner than Kymeta to launch this new era of connectivity with as we bring new offerings to the market in satellite and cellular communications around the world.”
“Given our existing working relationship, we recognize the synergies that even closer partnership will bring, and our whole team is very excited to be joining Kymeta. Our service-based background enriches the extensive industry knowledge and expertise already present at Kymeta, creating a truly collaborative powerhouse with cutting-edge capabilities in the satellite communications industry,” added Isabel LeBoutillier, Managing Partner at Lepton.
Together, Kymeta and Lepton will bring better solutions to the market as each company’s resources will enhance the other’s ability to meet customers’ needs. Current Lepton customers will experience no interruption in service in the short-term and will continue receiving Lepton’s full suite of products, services, and support. Over the long-term, customers will enjoy the benefits of the joint Kymeta-Lepton collaboration, and they will continue to build on Lepton’s established excellence as a satellite service provider and Kymeta’s unique product and services portfolio.
About Kymeta
Kymeta is unlocking the potential of broadband satellite connectivity, combined with cellular networks, to satisfy the overwhelming demand for comms on the move and making mobile global. Lepton Global Solutions, part of Kymeta, hosts the company’s satellite connectivity solutions and offers unique, complete, and turnkey bundled solutions to the market based on best-in-class technologies and tailored customer-centric services that meet and exceed customer mission requirements. These solutions in tandem with the company’s flat-panel satellite antenna, the first of its kind, and Kymeta™ Connect services provide revolutionary mobile connectivity on satellite and hybrid satellite-cellular networks to customers around the world. Backed by U.S. and international patents and licenses, the Kymeta terminal addresses the need for lightweight, slim, and high-throughput communication systems that do not require mechanical components to steer toward a satellite. Kymeta makes connecting easy – for any vehicle, vessel, or fixed platform.
Kymeta is a privately held company based in Redmond, Washington.
For more information, visit kymetacorp.com .
About Lepton
Lepton Global Solutions specializes in the engineering and delivery of customized, yet cost-effective, turnkey satellite communications solutions to commercial and government customers. Lepton’s end-to-end solutions, which go beyond managed satellite services to include VSAT equipment installation, 24×7 technical support and customized back end IT infrastructure, are tailored to meet customer-specific needs.
Lepton is headquartered outside of Washington, D.C. in Tysons Corner, Virginia.
For additional information, please visit www.leptonglobal.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200818005069/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 14:00:00 CEST | Press release
First commercial femtosecond laser image-guided, high precision trabeculotomy (FLIGHT) treatments mark a new era in interventional glaucoma; one where precision, safety, and the patient experience define the new standard of care ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful inno
BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 14:00:00 CEST | Press release
Company will demonstrate how high-quality, well-characterized biospecimens are critical to the success of both new approach methodologies (NAMs) and traditional studies BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures
IHS Towers Publishes 2025 Sustainability Report26.5.2026 12:34:00 CEST | Press release
IHS Holding Limited (NYSE: IHS) (“IHS Towers”) group, one of the largest independent owners, operators, and developers of shared communications infrastructure in the world by tower count, has today published its 2025 Sustainability Report. The report covers sustainability activities from January 1, 2025 to December 31, 2025 and demonstrates IHS Towers’ continued commitment to its stakeholders, including, but not limited to, its employees, customers, suppliers, local communities, regulators, governments and shareholders. IHS Towers’ vision is to help create a connected world, where mobile connectivity promotes continued economic growth and social development. The communications infrastructure it provides is vital to enabling that connectivity. In 2025, IHS Towers continued to advance its four-pillar sustainability strategy – focusing on ethics and governance, environment and climate change, education and economic growth, our people and communities – as detailed in this report. Sam Darwi
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 202626.5.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies Global Healthcare Conference on June 3, 2026 and will participate in a fireside chat at 12:45pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational CO
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
